Lyvgen Biopharma
PrivateLast Round
Series C
Feb 23, 2021
Total Funding Raised
$30M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lyvgen Biopharma is a biotechnology company that develops novel immuno-oncology (IO) agonist antibodies for cancer therapy using its proprietary xLinkAb platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lyvgen Biopharma Comparables
Compare Lyvgen Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pyxis Oncology | 79% | |
| Adagene | 78% | |
| Alligator Bioscience | 77% | |
Lyvgen Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 23, 2021 | ||||
| Series B | Jul 16, 2018 | ||||
| Series A | May 5, 2016 |
Lyvgen Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series C |
| Morningside Ventures | Series B, Series A |
| Chengwei Capital | Series C |
| 6 Dimensions Capital | Series B |
| Shanghai Free Trade Zone Fund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 3576% MoM, from 38 to 1.4K.
- Jan 7, 2026
Monthly visitors increased 129% MoM.
Lyvgen Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lyvgen Biopharma's valuation, stock price, and market status.